FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025226934> ?p ?o ?g. }

• W2025226934 endingPage "1688" @default.
• W2025226934 startingPage "1681" @default.
• W2025226934 abstract "The aim of the present study was to evaluate the potency of epidermal growth factor receptor (EGFR) pathway inhibition achieved by combining cetuximab (CET), an anti-EGFR monoclonal antibody, and celecoxib (CXB), a cyclooxygenase-2 (COX-2) inhibitor, in oral squamous cell carcinoma (OSCC) in vitro and in vivo. The OSCC cell line, HSC3, was treated with CET (0-400 µg/ml), CXB (0-40 µM), or a combination of both at a range of concentrations. Cell proliferation, apoptosis, migration and invasion were determined to assess the anticancer effects in vitro. The in vivo effects of CET and CXB on tumor cell growth were examined using an OSCC xenograft nude mouse model. In addition, downstream protein expression levels of EGFR, p-EGFR, PI3K, p-PI3K, AKT and p-Akt were evaluated by western blot analysis. It was found that the combination of low concentrations of CET and CXB significantly suppressed the proliferation, migration and invasion of the HSC3 tumor cells and decreased PEG2 production and VEGF expression in vitro, and inhibited tumor growth in vivo compared to the action of either agent alone. The results also showed that this combination significantly induced apoptosis and increased caspase-3 and caspase-8 activity compared to the action of either agent alone (P<0.01). Furthermore, the combination treatment significantly reduced the expression of p-EGFR, p-PI3K and p-Akt in the HSC3 cell line, which may contribute to the inhibition of tumor growth. Taken together, our findings revealed that the additive combination of CET and CXB is a potential drug candidate for the treatment of OSCC." @default.
• W2025226934 created "2016-06-24" @default.
• W2025226934 creator A5018071543 @default.
• W2025226934 creator A5027357793 @default.
• W2025226934 creator A5035991128 @default.
• W2025226934 creator A5046142438 @default.
• W2025226934 creator A5057640513 @default.
• W2025226934 creator A5079193103 @default.
• W2025226934 date "2014-07-16" @default.
• W2025226934 modified "2023-10-16" @default.
• W2025226934 title "Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo" @default.
• W2025226934 cites W1963503658 @default.
• W2025226934 cites W1965970474 @default.
• W2025226934 cites W1978498917 @default.
• W2025226934 cites W1993985442 @default.
• W2025226934 cites W1998988909 @default.
• W2025226934 cites W2005048851 @default.
• W2025226934 cites W2006467717 @default.
• W2025226934 cites W2012779526 @default.
• W2025226934 cites W2022071819 @default.
• W2025226934 cites W2035721831 @default.
• W2025226934 cites W2036882955 @default.
• W2025226934 cites W2047587366 @default.
• W2025226934 cites W2052254370 @default.
• W2025226934 cites W2059167706 @default.
• W2025226934 cites W2060163297 @default.
• W2025226934 cites W2064047613 @default.
• W2025226934 cites W2095495874 @default.
• W2025226934 cites W2097997344 @default.
• W2025226934 cites W2102367724 @default.
• W2025226934 cites W2111406172 @default.
• W2025226934 cites W2123206362 @default.
• W2025226934 cites W2127558096 @default.
• W2025226934 cites W2127640925 @default.
• W2025226934 cites W2146447599 @default.
• W2025226934 cites W2148000330 @default.
• W2025226934 cites W2158179945 @default.
• W2025226934 cites W2159487877 @default.
• W2025226934 cites W2165948908 @default.
• W2025226934 cites W2169748783 @default.
• W2025226934 cites W4244120980 @default.
• W2025226934 cites W51995314 @default.
• W2025226934 doi "https://doi.org/10.3892/or.2014.3334" @default.
• W2025226934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25328959" @default.
• W2025226934 hasPublicationYear "2014" @default.
• W2025226934 type Work @default.
• W2025226934 sameAs 2025226934 @default.
• W2025226934 citedByCount "22" @default.
• W2025226934 countsByYear W20252269342015 @default.
• W2025226934 countsByYear W20252269342016 @default.
• W2025226934 countsByYear W20252269342017 @default.
• W2025226934 countsByYear W20252269342018 @default.
• W2025226934 countsByYear W20252269342019 @default.
• W2025226934 countsByYear W20252269342020 @default.
• W2025226934 countsByYear W20252269342022 @default.
• W2025226934 countsByYear W20252269342023 @default.
• W2025226934 crossrefType "journal-article" @default.
• W2025226934 hasAuthorship W2025226934A5018071543 @default.
• W2025226934 hasAuthorship W2025226934A5027357793 @default.
• W2025226934 hasAuthorship W2025226934A5035991128 @default.
• W2025226934 hasAuthorship W2025226934A5046142438 @default.
• W2025226934 hasAuthorship W2025226934A5057640513 @default.
• W2025226934 hasAuthorship W2025226934A5079193103 @default.
• W2025226934 hasBestOaLocation W20252269341 @default.
• W2025226934 hasConcept C121608353 @default.
• W2025226934 hasConcept C126322002 @default.
• W2025226934 hasConcept C150903083 @default.
• W2025226934 hasConcept C159654299 @default.
• W2025226934 hasConcept C185592680 @default.
• W2025226934 hasConcept C190283241 @default.
• W2025226934 hasConcept C203014093 @default.
• W2025226934 hasConcept C207001950 @default.
• W2025226934 hasConcept C2776467144 @default.
• W2025226934 hasConcept C2779438470 @default.
• W2025226934 hasConcept C2779707156 @default.
• W2025226934 hasConcept C2779998722 @default.
• W2025226934 hasConcept C29537977 @default.
• W2025226934 hasConcept C502942594 @default.
• W2025226934 hasConcept C542903549 @default.
• W2025226934 hasConcept C54355233 @default.
• W2025226934 hasConcept C55493867 @default.
• W2025226934 hasConcept C62112901 @default.
• W2025226934 hasConcept C71924100 @default.
• W2025226934 hasConcept C75217442 @default.
• W2025226934 hasConcept C81885089 @default.
• W2025226934 hasConcept C86554907 @default.
• W2025226934 hasConcept C86803240 @default.
• W2025226934 hasConcept C98274493 @default.
• W2025226934 hasConceptScore W2025226934C121608353 @default.
• W2025226934 hasConceptScore W2025226934C126322002 @default.
• W2025226934 hasConceptScore W2025226934C150903083 @default.
• W2025226934 hasConceptScore W2025226934C159654299 @default.
• W2025226934 hasConceptScore W2025226934C185592680 @default.
• W2025226934 hasConceptScore W2025226934C190283241 @default.
• W2025226934 hasConceptScore W2025226934C203014093 @default.
• W2025226934 hasConceptScore W2025226934C207001950 @default.
• W2025226934 hasConceptScore W2025226934C2776467144 @default.
• W2025226934 hasConceptScore W2025226934C2779438470 @default.

• next